Retrospective Study of Botulinum Neurotoxin For Hemifacial Spasm – Experience Over 25 Years

This 25-year retrospective study in Malaysia demonstrates the safety and effectiveness of botulinum neurotoxin (BoNT) for treating Hemifacial Spasm, revealing decreasing BoNT doses and extending treatment intervals over time, with minimal complications and improved accessibility to BoNT treatment in private practice.

medRxiv 2023.10.03.23296410

doi: https://doi.org/10.1101/2023.10.03.23296410